September 2017: The Research Advocate

Research!America

The September 2017 of The Research Advocate is now online. 

Highlights from this month's issue: 

For every tragedy, communities come together to aid those in need. Many research institutions and health organizations are in full response mode as they offer resources to those affected by Hurricane Harvey.

Research!America’s National Health Research Forum will focus on potential solutions in panel discussions Thursday, September 7, 11:30 a.m. – 3:00 p.m. ET, at the Newseum in Washington, D.C. Experts representing academia, patient groups, government, industry and scientific societies will discuss what it will take to make dramatic strides against deadly and debilitating health threats.

With congressional FY18 budget negotiations underway, Research!America will be hosting a digital advocacy initiative to urge Congress to #RaisetheCaps on September 11-12.

More Americans say they would ‘very likely’ participate in a clinical trial if recommended by a doctor, an 11% increase from 2013, according to a new national public opinion survey commissioned by Research!America; and 46% say they admire people who volunteer for clinical trials ‘a great deal’, a 9% increase.

Serving the public interest is a shared responsibility between policymakers and scientists, said Mary Woolley, CEO and president of Research!America during a forum at the Stanley Manne Children’s Research Institute.

A member spotlight featuring UCB, a global biopharmaceutical research company is committed to making an impact on the lives of patients and those who care for them, particularly in the areas of neurology, immunology, and bone.

Download the entire September 2017 Research Advocate as a PDF.

Add comment

Plain text

  • No HTML tags allowed.
  • Adds node titles to internal links found in content (as HTML "title" attribute).
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
The capabilities are enormous, a little bit of research can pay off quite a bit in the long run.
Paul D’ Addario, retinitis pigmentosa patient